April/May 2009, Vol 2, No 3

Regulatory

MIPPA: First Broad Changes to Medicare Part D Plan Operations
Jean D. LeMasurier
; Babette Edgar, PharmD, MBA
Stakeholder Perspective by Mark A. Newsom, MSc

Clinical

ProvenCare: Geisinger’s Model for Care Transformation through Innovative Clinical Initiatives and Value Creation
Interview with Ronald A. Paulus, MD, MBA
Ronald A. Paulus, MD, MBA

Business

Increased Patient Cost-Sharing, Weak US Economy, and Poor Health Habits: Implications for Employers and Insurers
Melinda C. Haren, RN
; Kirk McConnell
; Arthur F. Shinn, PharmD, FASCP
Stakeholder Perspective by Paul Anthony Polansky, BSPharm, MBA

Commentary

The Paradox of Public Policy Reform: Change or Continuum?
Robert E. Henry
Are You Kidding Me? Clinical Comparative Effectiveness or Evidence-Based Medicine
Thomas Kaye, RPh, MBA, FASHP
The Integrated Patient-Centered Medical Home: Tools for Transforming Our Healthcare Delivery System
Matias A. Klein

Generic Drug Trends

New Legislations on Generics and Biosimilars Brewing in Congress
Dalia Buffery, MA, ABD

Industry Trends

Paying for Cancer Care: Economic Models Start to Emerge, Dovetailing Healthcare Reform
Caroline Helwick